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Background
The vital role of Protein-Protein Interactions (PPI) for Life
makes them the subject of a growing number of drug dis-
covery projects. Yet, the specific properties of PPI (often
described as flat, large and hydrophobic) require a dra-
matic paradigm shift in our way to design the small com-
pounds meant to modulate them with therapeutic
perspectives. To this end, successful inhibitors of PPI tar-
gets (iPPI) may be used to discover what singular proper-
ties make this type of inhibitors capable of binding to such
intricate surfaces. Among the properties from which les-
sons could be learnt, the 3D characteristics of iPPI have
been pinpointed as essential. Understanding the putative
shape profile of iPPI could help the design of a new gen-
eration of inhibitors.
Results
In an attempt to identify 3D characteristics, we have col-
lected the bioactive conformations of 84 orthosteric iPPI
and compared them to those of 1282 inhibitors of conven-
tional targets (e.g enzymes) collectively from different
databases (2P2I[1], PDBbind[2], PDB). Because the known
heavier and more hydrophobic character of iPPI could
conceal other characteristics, we have imposed that none
of the identified descriptors could correlate with the
hydrophobicity or the size of the compound. Four 3D
characteristics were highlighted (Figure 1). They describe
either the shape of the compounds (globularity) or the 3D
distributions of the hydrophobic and hydrophilic interact-
ing regions of the compounds (IW4, EDmin3, CW2: Vol-
Surf descriptors [3]). More specifically the most essential
property revealed in the analysis (EDmin3) illustrates how
iPPI manage to bind to the hydrophobic patches often
present at the core of PPI targets. The newly identified
properties were further confirmed as characteristic to iPPI
using the data of much larger datasets including our iPPI-
DB[4], eDrugs3D[5] and a representative subset of the bin-
dingDB [6].
Conclusions
Identifying low-molecular-weight iPPI is known to be a
difficult task. This has usually been translated into design-
ing compounds with higher size, aromaticity, and hydro-
phobicity. Yet, lessons are being learnt from iPPI bioactive
conformations in an attempt to circumvent this trend.
During this analysis, we demonstrated that the capacity to
bind a protein-protein interface partially rely on the com-
bination of several structural and electrostatic features
including the globularity and the distribution of hydrophi-
lic regions but most importantly of hydrophobic interact-
ing regions. More distinctively, iPPI seem to be
characterized by a significantly higher efficiency to bind
the hydrophobic patches often present at PPI interfaces.
The absence of correlation of this type of property with
the hydrophobicity and the size of the compounds could
open new ways to design iPPI with improved ligand and
lipophilic efficiencies and may allow the scientific commu-
nity to anticipate an era of more drug-like iPPI.* Correspondence: olivier.sperandio@inserm.fr
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Figure 1 Bioactive conformation of compound 1MQ as cocrystallized with Mdm2 (pdb code 4JVE). The compound is represented as
transparent molecular surface and molecular sticks. The value of highlighted descriptors are : EDmin3 = -3.18 kcal/mol (represented by the
green molecular field calculated using Moe 2012.10 at the levels of energy equal to -2.4 kcal/mol using a dry probe), IW4 = 4.13 (represented by
the pink molecular field calculated using Moe 2012.10 at the levels of energy equal to -5.5 kcal/mol using a water probe), glob = 0.20
(represented by the molecular surface), and CW2 = 1.90 (represented by the proportion of pink surface over the full molecular surface).
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